| Literature DB >> 26222740 |
Sylvie Bradesi1, Iordanes Karagiannides2, Kyriaki Bakirtzi3, Swapna Mahurkar Joshi4, Georgios Koukos5, Dimitrios Iliopoulos5, Charalabos Pothoulakis4, Emeran A Mayer6.
Abstract
INTRODUCTION: Animal studies have shown that stress could induce epigenetic and transcriptomic alterations essential in determining the balance between adaptive or maladaptive responses to stress. We tested the hypothesis that chronic stress in rats deregulates coding and non-coding gene expression in the spinal cord, which may underline neuroinflammation and nociceptive changes previously observed in this model.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26222740 PMCID: PMC4519289 DOI: 10.1371/journal.pone.0130938
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Heatmap showing unsupervised clustering of expression Z-scores of 256 unique genes from the list of 701 differentially expressed mRNAs.
Fig 2Heatmap of expression Z-scores of 30 unique genes from the 70 differentially regulated gene list.
Networks of molecules identified from IPA analysis of the 70 genes list.
| ID | Molecules in Network | Focus Molecules | Top Functions |
|---|---|---|---|
| 1 | AGMAT,BMP2,C6orf211,CCDC58,DNAJC21,ELAVL1,FAM49B,GLOD4,GPRC5C,HIC2,HNF4A,HSD17B12,HSDL2,KCNC3,KIAA1551,KNTC1,L2HGDH,LAMA5,MAPK1,MLEC,MRTO4,NBAS,PCNP,PITPNB,PTRH2,RSBN1,RSL24D1,SCFD2,TNN,UBC,VMA21,ZC3H15,ZFP37,ZNF528,ZWILCH | 15 | Cell Death and Survival, Gene Expression, RNA Damage and Repair |
| 2 | Akt,CCR2,CDK4/6,CDKN2B,CLCF1,CMTM8,DHX9,ERK,ERK1/2,GDF15,gelatinase,GMFB,GPRC5C,HAMP,Hmgb1,ID4,IFNL2,IKBKE,IL6ST,Interferon alpha,LGI1,MMP11,NEDD9,Neuropilin,NFkB (complex),OSMR,PDGF-AA,PI3K (complex),PLAC8,PTRH2,SEMA3F,Stat1/3,Tgf beta,Vegf,Ybx1-ps3 | 12 | Connective Tissue Disorders, Inflammatory Disease, Skeletal and Muscular Disorders |
Canonical pathways generated by the IPA analysis of the 70 genes list.
| Ingenuity Canonical Pathways | -log(p-value) | p vallue | Ratio | Molecules |
|---|---|---|---|---|
| Small Cell Lung Cancer Signaling | 2.36E00 | 0.0044 | 2.25E-02 | IKBKE,CDKN2B |
| Mouse Embryonic Stem Cell Pluripotency | 2.11E00 | 0.00774 | 2.02E-02 | IL6ST,ID4 |
| IL-6 Signaling | 1.94E00 | 0.0114 | 1.61E-02 | IL6ST,IKBKE |
| PI3K/AKT Signaling | 1.9E00 | 0.0127 | 1.39E-02 | GDF15,IKBKE |
| Acute Phase Response Signaling | 1.64E00 | 0.0231 | 1.11E-02 | IL6ST,IKBKE |
| Role of JAK family kinases in IL-6-type Cytokine Signaling | 1.46E00 | 0.0344 | 3.7E-02 | IL6ST |
| TNFR2 Signaling | 1.41E00 | 0.0385 | 3.03E-02 | IKBKE |
| 4-1BB Signaling in T Lymphocytes | 1.37E00 | 0.042 | 2.78E-02 | IKBKE |
| Colorectal Cancer Metastasis Signaling | 1.35E00 | 0.0447 | 7.63E-03 | IL6ST,MMP11 |
| TWEAK Signaling | 1.34E00 | 0.052 | 2.63E-02 | IKBKE |
| Oncostatin M Signaling | 1.33E00 | 0.065 | 2.86E-02 | IL6ST |
| IL-17A Signaling in Fibroblasts | 1.32E00 | 0.079 | 2.5E-02 | IKBKE |
| April Mediated Signaling | 1.28E00 | 0.051 | 2.33E-02 | IKBKE |
| 4-1BB Signaling in T Lymphocytes | 1.37E00 | 0.042 | 2.78E-02 | IKBKE |
| Colorectal Cancer Metastasis Signaling | 1.35E00 | 0.0447 | 7.63E-03 | IL6ST,MMP11 |
| TWEAK Signaling | 1.34E00 | 0.052 | 2.63E-02 | IKBKE |
| Oncostatin M Signaling | 1.33E00 | 0.065 | 2.86E-02 | IL6ST |
Fig 3Unsupervised clustering of miRNA expression Z-scores.
List of 39mirRNA differentially expressed in control and stressed samples.
| mmu-miR-677 | 1.59063919 |
| hsa-miR-516a-5p | 1.846808511 |
| rno-miR-219-5p | 1.598183824 |
| rno-miR-219-2-3p | 1.552373074 |
| mmu-miR-1939 | 1.312844612 |
| mmu-let-7c-2* | 1.699867198 |
| rno-miR-30a | 1.68225084 |
| rno-miR-30e | 1.63203197 |
| rno-miR-19a | 1.628297362 |
| rno-miR-494 | 1.534276674 |
| rno-miR-15b | 1.529882353 |
| mmu-miR-582-3p | 1.525028935 |
| hsa-miRPlus-E1038 | 1.515845807 |
| rno-miR-19b | 1.452562327 |
| rno-miR-133a | 1.439674083 |
| rno-miR-26b | 1.434479419 |
| rno-miR-384-3p | 1.431055901 |
| rno-miR-129* | 1.413793103 |
| rno-miR-20b-5p | 1.410658307 |
| rno-miR-181a | 1.402365501 |
| hsa-miR-1264 | 1.400736335 |
| rno-miR-34a | 1.392950761 |
| hsa-miRPlus-F1222 | 1.390770252 |
| rno-miR-100 | 1.389264877 |
| rno-miR-23a | 1.388569875 |
| hsa-miR-1297 | 1.385174419 |
| rno-miR-20a | 1.378527947 |
| rno-miR-17-5p | 1.372731855 |
| rno-let-7b | 1.370829659 |
| rno-miR-423 | 1.362669246 |
| rno-miR-148b-3p | 1.338410596 |
| mmu-miR-1274a | 1.311891746 |
| rno-miR-186 | 1.298256538 |
| hsa-miR-1274b | 1.287296898 |
| hsa-miR-1280 | 1.282561405 |
| rno-miR-29c | 1.450121246 |
| rno-miR-24 | 1.301975641 |
| rno-miR-181d | 1.289013075 |
| rno-miR-290 | 1.257022123 |
Networks of molecules identified from IPA analysis of the 30 miRNA list.
| ID | Molecules in Network | Score | Focus Molecules |
|---|---|---|---|
| 1 | EIF2C2,hydrogen peroxide,INS,mir-17,mir-19,mir-24,mir-29,mir-30,mir-34,mir-99,mir-133,mir-154,mir-181,mir-186,mir-219,mir-290,miR-148b-3p/miR-148a-3p/miR-152 (includes others),miR-17-5p/miR-20b-5p/miR-93-5p (includes others),miR-181a-5p/miR-181b-5p/miR-181a (includes others),miR-186-5p/miR-186,miR-18b-5p/miR-18a-5p/miR-18a (includes others),miR-19b-3p/miR-19b/miR-19a-3p,miR-219-2-3p,miR-219-5p,miR-24-3p/miR-24,miR-29a-5p/miR-29a*,miR-382-5p/miR-382,miR-409-5p,miR-487b/miR-487b-3p,miR-494/miR-494-3p,miR-539-5p/miR-539,miR-99a-5p/miR-100-5p/miR-99b-5p (includes others),MYLIP,PPARA,STAT3 | 47 | 18 |
| 2 | 25-hydroxy-vitamin D3,ARID4B,BNIP2,CCNE2,CCNF,DBF4 (includes EG:10926),DGCR8,DROSHA,EPHB6,estrogen receptor,FSH,Gulo,hCG,let-7,let-7a-3p/let-7f-1-3p/let-7b-3p (includes others),MAP2K1/2,MICA,mir-15,mir-17,mir-23,mir-26,mir-30,mir-181,mir-1297,miR-17-5p/miR-20b-5p/miR-93-5p (includes others),miR-181a-5p/miR-181b-5p/miR-181a (includes others),miR-18b-5p/miR-18a-5p/miR-18a (includes others),miR-20a-3p/miR-20a*,miR-26a-5p/miR-26b-5p,MYLIP,PHF6,PNPT1,TRIB1,Vegf,XPO5 | 25 | 11 |
List of predicted interactions between miRNA from the 39 list and genes from the 70 genes list, using the Ingenuity miRNA target filter.
| Symbol | Fold Change | Confidence | Symbol |
|---|---|---|---|
| miR-148b-3p (and other miRNAs w/seed CAGUGCA) | 1.338 | High (predicted) | IL6ST |
| miR-17-5p (and other miRNAs w/seed AAAGUGC) | 1.411 | High (predicted) | IL6ST |
| miR-181a-5p (and other miRNAs w/seed ACAUUCA) | 1.402 | High (predicted) | DNAJC21 |
| miR-19b-3p (and other miRNAs w/seed GUGCAAA) | 1.453 | High (predicted) | IL6ST |
| miR-24-3p (and other miRNAs w/seed GGCUCAG) | 1.302 | Moderate (predicted) | IKBKE |
Fig 4Real Time RT-PCR verification of selected gene expression after chronic WA stress.
IL6ST was significantly up-regulated in stress samples compared to controls while both STAT3 and GFAP were significantly reduced. P<0.5, n = 4 in each group.
Fig 5Real Time RT-PCR verification of selected miRNA expression after chronic WA stress.
Mir17-5p was significantly up-regulated in samples from stressed rats compared to controls. P<0.5, n = 4 in each group.
Fig 6Representative images of mir-17-5p In situ hybridization in the dorsal horn of the spinal cord using the NBT-BCP detection system.
A) Spinal cord isolated from control rats. B) Spinal cord isolated from stressed rats. Increased mir-17-5p staining is observed in the dorsal horn. Scale bar is 100mM.
Fig 7Expression of mi17-5p in the spinal cord assessed by in situ hybridization with co-immunofluorescence staining for astrocytes (GFAP) and DAPI.
A) In situ hybridization of mir17-5p (red) with co-immunostaining for GFAP (green) and DAPI (blue) in the dorsal horn of the spinal cord from control rats. B) In situ hybridization of mir17-5p (red) with co-immunostaining for GFAP (green) and DAPI (blue) in the dorsal horn of the spinal cord from stressed rats. Arrows indicate evidence of mir-17-5p staining in peri-nuclear space colocalizing with astrocytes. Scale car = 50mM. C) In situ hybridization with scramble negative control probe with co-immunofluorescence staining for astrocytes (GFAP) in the dorsal horn of the spinal cord from a stressed rat. Scale bar = 200 mM.
Fig 8Effect of the miRCURY LNA mir17-5p inhibitor or scramble control on stress-induced visceral hyperalgesia.
A) EMG response to graded CRD at baseline and 24 hours following the 10th stress session showed overall increase of the EMG response to CRD with significant increased at 40 mmHg consistent with stress-induced visceral hyperalgesia n = 8 *P<0.05 two-way ANOVA followed by Bonferroni post test. B) Stressed rats treated with the LNAmir17-5p inhibitor exhibit increased EMG response to CRD at day 11 compared with baseline indicating visceral hyperalgesia n = 6, *P<0.05 two-way ANOVA followed by Bonferroni post test. C) The mean change from baseline was significantly higher in stressed rats treated with the LNAmir17-5p inhibitor (n = 6) compared with stressed rats treated with the control scramble (n = 8) indicating an exacerbation of visceral sensitivity *P<0.05 two-way ANOVA followed by Bonferroni post test.
Fig 9Schematic representation of the modulation of the IL6ST/STAT3/GFAP system in our model.
Binding of IL-6-type cytokines to gp130 induces gp130 dimerization, and subsequent intracellular signaling cascades leading to STAT1/3 phosphorylation by JAKS. After dimerization and translocation to the nucleus, STAT1/3 act as a transcriptional factor for multiple genes including GFAP. SOCS3 may act as an inhibitor of STAT3-induced regulation of GFAP via inhibition of STAT1/3 phosphorylation. Mir17-5p is a potential regulator of the system by modulating the expression of IL6ST and STAT3.